After this stock issue, it is planned to be listed on the gem, which has high investment risk. GEM companies have the characteristics of large investment in innovation, uncertainty about the success of the integration of new and old industries, still in the growth stage, high operation risk, unstable performance and high delisting risk. Investors are facing greater market risk. Investors should fully understand the investment risks of the gem and the risk factors disclosed by the company, and make investment decisions prudently.
Chengda Pharmaceutical Co., Ltd
Chengda Pharmaceuticals Co.,Ltd.
(No. 36, Huanghe Road, Huimin street, Jiashan County, Jiaxing City, Zhejiang Province)
Prospectus for initial public offering and listing on GEM
Sponsor (lead underwriter)
(No. 1508, Xinzha Road, Jing’an District, Shanghai)
Issuer statement
Any decision or opinion made by the CSRC and the exchange on this issuance does not indicate that they guarantee the authenticity, accuracy and integrity of the registration application documents and the information disclosed, nor do they indicate that they make substantive judgment or guarantee on the profitability, investment value of the issuer or the income of investors. Any statement to the contrary is a false statement.
According to the provisions of the securities law, the issuer shall be responsible for the changes in the operation and income of the issuer after the shares are issued according to law; Investors independently judge the investment value of the issuer, make investment decisions independently, and bear the investment risks caused by changes in the operation and income of the issuer or changes in the stock price after the shares are issued according to law. The issuer and all directors, supervisors and senior managers promise that there are no false records, misleading statements or major omissions in the prospectus and other information disclosure materials, and bear corresponding legal liabilities.
The controlling shareholder and actual controller of the issuer promise that there are no false records, misleading statements or major omissions in this prospectus, and bear corresponding legal liabilities.
The person in charge of the company, the person in charge of accounting and the person in charge of the accounting agency shall ensure that the financial and accounting materials in the prospectus are true and complete.
The issuer and all directors, supervisors, senior managers, controlling shareholders, actual controllers, sponsors and underwriting securities companies promise to compensate investors for losses in securities issuance and trading due to false records, misleading statements or major omissions in the issuer’s prospectus and other information disclosure materials.
The sponsor and the securities service institution promise to compensate the investors for the losses caused to the investors due to the false records, misleading statements or major omissions in the documents prepared and issued for the issuer’s public offering.
Overview of this offering
Type of shares issued: RMB ordinary shares (A shares)
24174035 shares, and the shares publicly issued after the completion of this issuance account for 25% of the total number of shares issued by the company. All of this offering is a public offering of new shares, and the original shareholders do not offer shares to the public
The par value of each share is RMB 1.00
The issue price per share is RMB 72.69
Issue date: January 10, 2022
Stock exchanges and plates to be listed Shenzhen Stock Exchange gem
The total share capital after issuance is 96696140 shares
Sponsor (lead underwriter) Everbright Securities Company Limited(601788)
Signing date of prospectus: January 14, 2022
Tips on major events
The company specially reminds investors that before making investment decisions, they must carefully read the text of this prospectus and pay special attention to the following important matters. 1、 Distribution of accumulated undistributed profits before issuance
According to the resolution of the company’s fifth extraordinary general meeting in 2020, the accumulated undistributed profits before the issuance shall be jointly enjoyed by the new and old shareholders after the issuance according to their respective proportion of shares. 2、 Dividend distribution policy after the company’s issuance and listing
The company’s fifth extraordinary general meeting in 2020 deliberated and approved the articles of Association (Draft) applicable after listing, which stipulates the company’s post listing dividend distribution policy. For details, see “(I) post issuance dividend distribution policy and decision-making procedures” of “II. Issuer’s dividend distribution policy” in “section 10 investor protection” of this prospectus. 3、 Main operating conditions after the audit deadline of financial report (I) main financial information after the audit deadline
The audit deadline of the company’s financial report is June 30, 2021. According to the review report (Zhong Hui Zi [2021] No. 08425) issued by Zhonghua Certified Public Accountants (special general partnership), the main financial information reviewed by the company on September 30, 2021, July September 2021 and January September 2021 are as follows:
1. Main data of consolidated balance sheet
Unit: 10000 yuan
Change proportion of the project from September 30, 2021 to December 31, 2020
Total assets 61628.61 53420.67 15.36%
Total liabilities 11644.70 7529.85 54.65%
Total owner’s equity 49983.92 45890.82 8.92%
Including: owner’s equity attributable to the parent company 49912.66 45806.29 8.96%
As of September 30, 2021, the total assets of the issuer were 616.2861 million yuan, an increase of 15.36% over the end of the previous year; The total liabilities were 116.447 million yuan, an increase of 54.65% over the end of the previous year, mainly due to the company’s new bank loan of 35 million yuan for plant expansion projects.
2. Main data of consolidated income statement
Unit: 10000 yuan
Change proportion of the project from January to September 2021 to January to September 2020
Operating income 28986.00 26694.63 8.58%
Operating profit 8296.31 7795.11 6.43%
Total profit 8094.01 7721.77 4.82%
Net profit 7037.22 6529.38 7.78%
Net profit attributable to shareholders of parent company 7050.48 6610.67 6.65%
Net profit attributable to 6780.33 6536.42 3.73% shareholders of the parent company after deducting non recurring profits and losses
From January to September 2021, the company realized an operating revenue of 289.86 million yuan, an increase of 8.58% over January to September 2020; The net profit attributable to the shareholders of the parent company was 70.5048 million yuan, an increase of 6.65% over January September 2020. From January to September 2021, the company was in good operating condition.
Unit: 10000 yuan
Change proportion of the project from July to September 2021 to July to September 2020
Operating income 9470.83 9505.06 -0.36%
Operating profit 2212.45 2669.92 – 17.13%
Total profit 2103.17 2607.84 – 19.35%
Net profit 1950.26 2214.12 – 11.92%
Net profit attributable to shareholders of the parent company 1956.99 2214.91 – 11.64%
Net profit attributable to 2151.91 – 6.54% of shareholders of the parent company on February 22, 2011 after deducting non recurring profits and losses
From July to September 2021, the company’s operating revenue was basically the same as that from July to September 2020, but the operating profit, total profit, net profit, net profit attributable to shareholders of the parent company and net profit attributable to shareholders of the parent company after deducting non recurring profits and losses decreased compared with July to September 2020. Since 2021, due to the covid-19 pneumonia epidemic, the imbalance between supply and demand in the global material market and other factors, the price of raw material chemical products has continued to rise. From July to September 2021, the average purchase unit price of the company’s main raw materials chiral epichlorohydrin, trimethylamine hydrochloride (aqueous solution) and absolute ethanol increased by 32.67%, 17.41% and 21.42% respectively compared with the same period last year, resulting in an increase in the company’s operating costs. In order to reduce the adverse impact of the price rise of main raw materials on the company’s operating performance, the company has appropriately raised the price of some products after comprehensively considering the relationship between market supply and demand and competition. However, the effective exertion of price transmission mechanism needs a process, and the impact of the increase of sales price on business performance lags behind.
3. Consolidated cash flow statement data
Unit: 10000 yuan
Change proportion of the project from January to September 2021 to January to September 2020
Net cash flow from operating activities 8737.52 10391.61 – 15.92%
Net cash flow from investment activities -11630.17 -1368.14 750.07%
Net cash flow from financing activities 564.13 – 12558.24 – 104.49%
Net increase in cash and cash equivalents -2361.52 -3604.47 -34.48%
From January to September 2021, the net cash flow from the company’s operating activities was 87.3752 million yuan, a decrease of 15.92% compared with January to September 2020, mainly due to the increase in the price of raw materials, resulting in an increase of 16.06% in the cash paid by the company for purchasing goods and receiving labor services compared with January to September 2020. From January to September 2021, the net cash flow generated by the company’s investment activities was -116.3017 million yuan, mainly due to the increase in investment in the company’s plant expansion project. From January to September 2021, the net cash flow generated by the company’s financing activities was 5.6413 million yuan, mainly due to the company’s new bank borrowings. From January to September 2020, the net cash flow generated by the company’s financing activities was negative, mainly due to the abundant cash flow generated by the company’s operating activities from January to September 2020 and the repayment of some bank borrowings.
Unit: 10000 yuan
The project will change from July to September 2021 to July to September 2020
